These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3278814)
1. Bacterial cysteine conjugate beta-lyase and the metabolism of cysteine S-conjugates: structural requirements for the cleavage of S-conjugates and the formation of reactive intermediates. Vamvakas S; Berthold K; Dekant W; Henschler D Chem Biol Interact; 1988; 65(1):59-71. PubMed ID: 3278814 [TBL] [Abstract][Full Text] [Related]
2. Bacterial beta-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene. Dekant W; Vamvakas S; Berthold K; Schmidt S; Wild D; Henschler D Chem Biol Interact; 1986 Oct; 60(1):31-45. PubMed ID: 3536138 [TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of amino acid and glutathione S-conjugates in the Ames test. Vamvakas S; Elfarra AA; Dekant W; Henschler D; Anders MW Mutat Res; 1988 Sep; 206(1):83-90. PubMed ID: 2901035 [TBL] [Abstract][Full Text] [Related]
4. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. Dekant W; Berthold K; Vamvakas S; Henschler D; Anders MW Chem Res Toxicol; 1988; 1(3):175-8. PubMed ID: 2979728 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. Vamvakas S; Dekant W; Berthold K; Schmidt S; Wild D; Henschler D Biochem Pharmacol; 1987 Sep; 36(17):2741-8. PubMed ID: 3307787 [TBL] [Abstract][Full Text] [Related]
6. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes. Finkelstein MB; Dekant W; Anders MW Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of hexachloro-1,3-butadiene and its S-conjugates in the Ames test--role of activation by the mercapturic acid pathway in its nephrocarcinogenicity. Vamvakas S; Kordowich FJ; Dekant W; Neudecker T; Henschler D Carcinogenesis; 1988 Jun; 9(6):907-10. PubMed ID: 3286031 [TBL] [Abstract][Full Text] [Related]
8. Bioactivation of cysteine conjugates of 1-nitropyrene oxides by cysteine conjugate beta-lyase purified from Peptostreptococcus magnus. Kataoka K; Kinouchi T; Akimoto S; Ohnishi Y Appl Environ Microbiol; 1995 Nov; 61(11):3781-7. PubMed ID: 8526486 [TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of the cysteine S-conjugate sulfoxides of trichloroethylene and tetrachloroethylene in the Ames test. Irving RM; Elfarra AA Toxicology; 2013 Apr; 306():157-61. PubMed ID: 23416178 [TBL] [Abstract][Full Text] [Related]
10. The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells. Stevens J; Hayden P; Taylor G J Biol Chem; 1986 Mar; 261(7):3325-32. PubMed ID: 3753976 [TBL] [Abstract][Full Text] [Related]
11. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. Lash LH; Sausen PJ; Duescher RJ; Cooley AJ; Elfarra AA J Pharmacol Exp Ther; 1994 Apr; 269(1):374-83. PubMed ID: 8169843 [TBL] [Abstract][Full Text] [Related]
12. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Iyer RA; Anders MW Anesthesiology; 1996 Dec; 85(6):1454-61. PubMed ID: 8968194 [TBL] [Abstract][Full Text] [Related]
13. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A). Iyer RA; Anders MW Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416 [TBL] [Abstract][Full Text] [Related]
14. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates. Commandeur JN; King LJ; Koymans L; Vermeulen NP Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263 [TBL] [Abstract][Full Text] [Related]
15. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase. Stevens JL; Hatzinger PB; Hayden PJ Drug Metab Dispos; 1989; 17(3):297-303. PubMed ID: 2568912 [TBL] [Abstract][Full Text] [Related]
16. Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds. Finkelstein MB; Vamvakas S; Bittner D; Anders MW Chem Res Toxicol; 1994; 7(2):157-63. PubMed ID: 8199303 [TBL] [Abstract][Full Text] [Related]
17. Human mitochondrial and cytosolic branched-chain aminotransferases are cysteine S-conjugate beta-lyases, but turnover leads to inactivation. Cooper AJ; Bruschi SA; Conway M; Hutson SM Biochem Pharmacol; 2003 Jan; 65(2):181-92. PubMed ID: 12504794 [TBL] [Abstract][Full Text] [Related]
18. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes. Vamvakas S; Dekant W; Henschler D Mutat Res; 1989 Apr; 222(4):329-35. PubMed ID: 2704384 [TBL] [Abstract][Full Text] [Related]